Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease (MeynD-DBS)

This study has been completed.
Information provided by (Responsible Party):
Jens Kuhn, University of Cologne Identifier:
First received: March 25, 2010
Last updated: June 6, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):